Vascular Endothelial Growth Factor-A–Induced Chemotaxis of Monocytes Is Attenuated in Patients With Diabetes Mellitus | Zendy

Johannes Waltenberger | Zendy; Juliane Lange | Zendy; Andrea Kranz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Vascular Endothelial Growth Factor-A–Induced Chemotaxis of Monocytes Is Attenuated in Patients With Diabetes Mellitus

Author(s) -

Johannes Waltenberger,

Juliane Lange,

Andrea Kranz

Publication year - 2000

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.102.2.185

Subject(s) - medicine , monocyte , chemotaxis , vascular endothelial growth factor , endocrinology , ex vivo , diabetes mellitus , in vivo , immunology , receptor , vegf receptors , biology , microbiology and biotechnology

Vascular endothelial growth factor-A (VEGF-A) acts on endothelial cells and monocytes, 2 cell types that participate in the angiogenic and arteriogenic process in vivo. Thus far, it has not been possible to identify differences in individual responses to VEGF-A stimulation because of the lack of an ex vivo assay.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research